Lenz Therapeutics to Receive Upfront Payment and Profit Share from Arrotex Vizz Sales

LENZ Therapeutics, Inc. will receive an upfront payment and corresponding profit sharing from the sales of Arrotex Vizz.

The translated content is provided by third-party software.

Disclaimer: The market involves risks; please invest with caution. This article was generated by an AI large language model based on public information and does not represent the views of Sina Finance. All information, data, and charts contained herein are for reference only and do not constitute any form of investment advice or basis for decision-making. For accurate information, please refer to the actual official announcements. If you have any questions, please contact: biz@staff.sina.com.cn.

Responsible Editor: Xiaolang Express